Indivior To Pay $600M To Settle Suboxone Charges
Indivior PLC said Friday it has agreed to pay $600 million to settle charges related to its opioid treatment Suboxone, ending litigation and investigations into claims about the safety of the...To view the full article, register now.
Already a subscriber? Click here to view full article